MCID: GST009
MIFTS: 45

Gastroschisis malady

Categories: Rare diseases, Gastrointestinal diseases, Fetal diseases

Aliases & Classifications for Gastroschisis

About this section
Sources:
10Disease Ontology, 45NIH Rare Diseases, 47Novoseek, 12DISEASES, 51Orphanet, 36MeSH, 65UMLS, 27ICD10, 29ICD9CM, 42NCIt, 59SNOMED-CT, 66UMLS via Orphanet, 28ICD10 via Orphanet, 37MESH via Orphanet
See all MalaCards sources

Aliases & Descriptions for Gastroschisis:

Name: Gastroschisis 10 45 47 12 51 36 65
Congenital Fissure of the Abdominal Cavity 45
 
Laparoschisis 51

Characteristics:

Orphanet epidemiological data:

51
gastroschisis:
Inheritance: Not applicable; Prevalence: 1-5/10000 (Europe),1-5/10000 (Austria),1-5/10000 (Belgium),1-5/10000 (Croatia),1-5/10000 (Denmark),1-5/10000 (France),1-5/10000 (Germany),1-9/100000 (Hungary),1-5/10000 (Ireland),1-9/100000 (Italy),1-5/10000 (Malta),1-5/10000 (Netherlands),1-5/10000 (Norway),1-5/10000 (Poland),1-5/10000 (Portugal),1-9/100000 (Spain),1-5/10000 (Switzerland),1-5/10000 (United Kingdom),1-9/100000 (Ukraine); Age of onset: Antenatal,Neonatal; Age of death: normal life expectancy

Classifications:



External Ids:

Disease Ontology10 DOID:11044
ICD1027 Q79.3
ICD9CM29 756.73
MeSH36 D020139
NCIt42 C84725
SNOMED-CT59 72951007
Orphanet51 2368
UMLS via Orphanet66 C0265706
ICD10 via Orphanet28 Q79.3
MESH via Orphanet37 D020139
UMLS65 C0265706

Summaries for Gastroschisis

About this section
Wikipedia:68 Gastroschisis represents a congenital defect characterised by a defect in the anterior abdominal wall... more...

MalaCards based summary: Gastroschisis, also known as congenital fissure of the abdominal cavity, is related to crohn's disease and oral squamous cell carcinoma, and has symptoms including gastroschisis, intestinal atresia/stenosis/absence/agenesis/hypoplasia (excludes duodenum) and mesenterium anomaly/common mesentery/mesenteric adhesion. An important gene associated with Gastroschisis is BMP1 (Bone Morphogenetic Protein 1), and among its related pathways are IL-9 Signaling Pathways and their Primary Biological Effects in Different Immune Cell Types and Immune response_MIF-mediated glucocorticoid regulation. Affiliated tissues include skin, liver and breast, and related mouse phenotypes are muscle and hematopoietic system.

Related Diseases for Gastroschisis

About this section

Diseases related to Gastroschisis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 455)
idRelated DiseaseScoreTop Affiliating Genes
1crohn's disease30.2F5, IL6
2oral squamous cell carcinoma29.8F5, MPO
3retinitis pigmentosa29.8F5, IL6
4meconium aspiration syndrome26.7ADD1, BMP1, F5, ICAM1, IL6, MPO
5abdominal wall defect10.6
6laparoschisis10.3
7paraomphalocele10.3
8breast cancer10.3
9lymphoma10.3
10sugarman brachydactyly10.3F5, IL6
11oral mucosa leukoplakia10.3IL6, NPPA
12maple bark strippers' lung10.2F5, IL6
13hepatitis10.2
14neuronitis10.2
15eccrine sweat gland neoplasm10.2F5, IL6
16focal embolic glomerulonephritis10.2IL6, MPO
17protein s deficiency10.2F5, IL6
18partial circumpapillary choroid dystrophy10.2IL6, MPO
19melanoma10.2
20endotheliitis10.2
21idiopathic hypersomnia10.2MPO, NPPA
22papillary pattern testicular yolk sac tumor10.2F5, MPO
23cutaneous paget's disease10.1F5, IL6
24adenocarcinoma10.1
25retinitis10.1
26acute zonal occult outer retinopathy10.1F5, IL6
27signet ring cell variant cervical mucinous adenocarcinoma10.1NPPA, TGFB3
28focal labyrinthitis10.1F5, MPO
29villoglandular variant cervical mucinous adenocarcinoma10.1IL6, MPO
30neuroblastoma10.1
31adult spinal cord glioblastoma multiforme10.1F5, IL6
32fetal erythroblastosis10.1F5, MPO
33lung cancer10.1
34arthritis10.1
35cervicitis10.1
36cerebritis10.1
37periodontitis10.1
38influenza10.1
39cardiomyopathy10.1
40childhood kidney angiomyolipoma10.1IL6, MPO
41childhood kidney cell carcinoma10.0ICAM1, IL6
42monckeberg arteriosclerosis10.0ICAM1, IL6
43spinal canal and spinal cord meningioma10.0IL6, NPPA, TGFB3
44parasitic helminthiasis infectious disease10.0ICAM1, TGFB3
45dancing eyes-dancing feet syndrome10.0ICAM1, IL6
46dyskinesia of esophagus10.0ICAM1, IL6
47hypopharynx cancer10.0ICAM1, IL6
48schizophrenia10.0
49rheumatoid arthritis10.0
50hodgkin lymphoma10.0

Graphical network of the top 20 diseases related to Gastroschisis:



Diseases related to gastroschisis

Symptoms for Gastroschisis

About this section

Symptoms:

 51
  • gastroschisis
  • intestinal atresia/stenosis/absence/agenesis/hypoplasia (excludes duodenum)
  • mesenterium anomaly/common mesentery/mesenteric adhesion

Drugs & Therapeutics for Gastroschisis

About this section

Drugs for Gastroschisis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 26)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
Metoclopramideapproved, investigationalPhase 3102364-62-54168
Synonyms:
(metaclopramide)4-Amino-5-chloro-N-(2-diethylamino-ethyl)-2-methoxy-benzamide
(metoclopramide)4-Amino-5-chloro-N-(2-diethylamino-ethyl)-2-methoxy-benzamide
1,5-Dimethyl-2-phenyl-1,2-dihydro-pyrazol-3-one
2-Methoxy-4-amino-5-chloro-N,N-(dimethylaminoethyl)benzamide
2-Methoxy-4-amino-5-chloro-N,N-dimethylaminoethyl)benzamide
2-Methoxy-5-chloroprocainamide
2-methoxy-4-amino-5-chloro-N,N-(dimethylaminoethyl)benzamide
2-methoxy-5-chloroprocainamide
2576-84-3 (di-hydrochloride)
364-62-5
4 Amino-5-chloro-N-(2-(diethylamino)ethyl)-2-methoxybenzamide
4-Amino-5-chloro-2-methoxy-N-(beta-diethylaminoethyl)benzamide
4-Amino-5-chloro-N-(2-(diethylamino)ethyl)-2-methoxybenzamide
4-Amino-5-chloro-N-(2-(diethylamino)ethyl)-o-anisamide
4-Amino-5-chloro-N-(2-diethylamino-ethyl)-2-methoxy-benzamide
4-Amino-5-chloro-N-(2-diethylamino-ethyl)-2-methoxy-benzamide (Mcp)
4-Amino-5-chloro-N-(2-diethylamino-ethyl)-2-methoxy-benzamide (metoclopramide)
4-Amino-5-chloro-N-(2-diethylamino-ethyl)-2-methoxy-benzamide(Metoclopramide)
4-amino-5-chloro-2-Methoxy-N-(beta-diethylaminoethyl)benzamide
4-amino-5-chloro-N-(2-(Diethylamino)ethyl)-2-methoxybenzamide
4-amino-5-chloro-N-(2-(Diethylamino)ethyl)-O-anisamide
4-amino-5-chloro-N-(2-diethylaminoethyl)-2-methoxybenzamide
4-amino-5-chloro-N-[2-(diethylamino)ethyl]-2-methoxybenzamide
5-Chloro-2-methoxyprocainamide
54143-57-6 (mono-hydrochloride, mono-hydrate)
7232-21-5 (mono-hydrochloride)
AB00053498
AC1L1HKD
AKOS000280832
ARONIS24307
Apo-Metoclop
BPBio1_000217
BPBio1_001100
BRD-K75641298-001-01-5
BRD-K75641298-003-05-2
BRN 1884366
BSPBio_000197
BSPBio_002027
Benzamide, 4-amino-5-chloro-N-(2-(diethylamino)ethyl)-2-methoxy- (9CI)
Biomol-NT_000082
C07868
C14H22ClN3O2
CAS-7232-21-5
CHEBI:107736
CHEMBL86
CID4168
CLOPRA-"YELLOW"
Cerucal
Clopra
Clopra-Yellow
Clopromate
D00726
DB01233
DEL
DEL 1267
DivK1c_000069
Duraclamid
EINECS 206-662-9
Elieten
Elieten (TN)
Emetid
Emitasol
Emperal
Eucil
Gastrese
Gastro-Timelets
Gastrobid
Gastromax
Gastronerton
Gastrosil
Gastrotablinen
Gastrotem
HMS2089G16
IDI1_000069
Imperan
KBio1_000069
KBio2_002118
KBio2_004686
 
KBio2_007254
KBio3_001527
KBioGR_001307
KBioSS_002118
L001078
LS-20038
Lopac-M-0763
Lopac0_000762
Maxeran
Maxolon
Meclopran
Metaclopramide
Metaclopromide
Metamide
Methochlopramide
Methoclopramide
Metochlopramide
Metoclol
Metoclopramida
Metoclopramida [INN-Spanish]
Metoclopramide
Metoclopramide (JP15/INN)
Metoclopramide Hcl
Metoclopramide Hydrochloride
Metoclopramide Intensol
Metoclopramide Monohydrochloride, Monohydrate
Metoclopramide Omega
Metoclopramide [INN:BAN:JAN]
Metoclopramidum
Metoclopramidum [INN-Latin]
Metocobil
Metonia
Metramid
MolPort-000-883-854
Moriperan
Mygdalon
N-(Diethylaminoethyl)-2-methoxy-4-amino-5-chlorobenzamide
NCGC00015643-01
NCGC00015643-02
NCGC00015643-03
NCGC00015643-08
NCGC00024440-03
NCGC00024440-04
NCI60_003185
NINDS_000069
Neu-Sensamide
Nu-Metoclopramide
Octamide
Parmid
Paspertin
Peraprin
Plasil
Plasil (pharmaceutical)
Pms-Metoclopramide
Pramidin
Pramiel
Pramin
Prestwick0_000209
Prestwick1_000209
Prestwick2_000209
Prestwick3_000209
Primperan
Reclomide
Reglan
Reliveran
SPBio_001740
SPBio_002118
ST024773
Spectrum2_001720
Spectrum3_000504
Spectrum4_000964
Spectrum5_001449
Spectrum_001638
Terperan
Terperan (TN)
UNII-L4YEB44I46
bmse000779
metoclopramide
o-Anisamide, 4-amino-5-chloro-N-(2-(diethylamino)ethyl)- (8CI)
2
DopamineapprovedPhase 3308462-31-7, 51-61-6681
Synonyms:
(3H)-Dopamine
.Beta.-(3,4-Dihydroxyphenyl)ethylamine hydrochloride
.alpha.-(3,4-Dihydroxyphenyl)-.beta.-aminoethane
1,2-Benzenediol, 4-(2-aminoethyl)- (9CI)
1,2-Benzenediol, 4-(2-aminoethyl)-, hydrochloride
1,2-Benzenediol, 4-(2-aminoethyl)-, labeled with tritium
153C5321-5FEE-4B0B-8925-F388F0EEEBD1
2-(3,4-Dihydroxyphenyl)ethylamine
2-(3,4-dihydroxyphenyl)ethylamine
2-benzenediol
3,4-Dihydroxyphenethylamine
3,4-Dihydroxyphenethylamine hydrochloride
3,4-Dihydroxyphenylethylamine
3,4-dihydroxyphenethylamine
3-Hydroxtyramine
3-Hydroxytyramine
3-Hydroxytyramine Hydrobromide
3-Hydroxytyramine hydrochloride
4-(2-Aminoethyl)-1,
4-(2-Aminoethyl)-1,2-benzenediol
4-(2-Aminoethyl)-1,2-bezenediol
4-(2-Aminoethyl)-Pyrocatechol
4-(2-Aminoethyl)benzene-1,2-diol
4-(2-Aminoethyl)catechol
4-(2-Aminoethyl)pyrocatechol
4-(2-Aminoethyl)pyrocatechol hydrochloride
4-(2-aminoethyl)-pyrocatechol
50444-17-2
51-61-6
62-31-7 (HYDROCHLORIDE)
AC1L19S5
AC1Q54AX
AC1Q54AY
AKOS003790978
ASL 279
BIDD:ER0506
BPBio1_001123
BSPBio_001932
Biomol-NT_000001
C03758
CHEBI:18243
CHEMBL59
CID681
D07870
DB00988
Deoxyepinephrine
DivK1c_000780
Dopamin
Dopamina
Dopamina [INN-Spanish]
Dopamine
Dopamine (INN)
Dopamine (USAN)(*hydrochloride*)
Dopamine Hcl
Dopamine Hydrochloride
Dopamine [INN:BAN]
Dopaminum
Dopaminum [INN-Latin]
Dopastat
Dophamine
Dynatra
EINECS 200-110-0
HSDB 3068
Hydroxytyramin
Hydroxytyramine
IDI1_000780
IP 498
Intropin
Intropin [*hydrochloride*]
 
KBio1_000780
KBio2_001492
KBio2_002388
KBio2_002484
KBio2_004060
KBio2_004956
KBio2_005052
KBio2_006628
KBio2_007524
KBio2_007620
KBio3_001152
KBio3_002867
KBio3_002962
KBioGR_001129
KBioGR_002388
KBioGR_002484
KBioSS_001492
KBioSS_002393
KBioSS_002491
KW-3-060
L-DOPAMINE
L000232
LDP
LS-159
Lopac-H-8502
Lopac0_000586
Medopa (TN)
MolPort-001-641-000
NCGC00015519-01
NCGC00015519-08
NCGC00096050-01
NCGC00096050-02
NCGC00096050-03
NCGC00096050-04
NCGC00096050-05
NINDS_000780
NSC 173182
NSC169105
NSC173182
Oprea1_088821
Oxytyramine
Pyrocatechol, 4-(2-aminoethyl)- (8CI)
Pyrocatechol, 4-(2-aminoethyl)-, hydrochloride
Revimine
Revivan
SPBio_001205
SPECTRUM1505155
ST048774
STK301601
Spectrum2_001023
Spectrum3_000406
Spectrum4_000525
Spectrum5_000945
Spectrum_001012
UNII-VTD58H1Z2X
UPCMLD0ENAT5885989:001
a-(3,4-Dihydroxyphenyl)-b-aminoethane
alpha-(3,4-Dihydroxyphenyl)-beta-aminoethane
cMAP_000036
cMAP_000065
dopamine
hydroxytyramine
intropin
m-Hydroxytyramine hydrochloride
nchembio.105-comp9
nchembio.107-comp4
nchembio.284-comp1
nchembio.78-comp16
nchembio.89-comp3
nchembio705-8
nchembio801-comp8
3Neurotransmitter AgentsPhase 314795
4AntiemeticsPhase 33213
5Gastrointestinal AgentsPhase 3, Phase 1, Phase 26401
6Peripheral Nervous System AgentsPhase 318510
7Dopamine D2 Receptor AntagonistsPhase 3258
8Dopamine AgentsPhase 33084
9Dopamine AntagonistsPhase 3927
10Fat Emulsions, IntravenousPhase 229
11Liver ExtractsPhase 23572
12
BilirubinPhase 2103635-65-45280352
Synonyms:
(4Z,15Z)-Bilirubin IXa
(Z,Z)-Bilirubin IXa
1,10,19,22,23,24-Hexahydro-2,7,13,17-tetramethyl-1,19-dioxo-3,18-divinyl-Biline-8,12-dipropionate
1,10,19,22,23,24-Hexahydro-2,7,13,17-tetramethyl-1,19-dioxo-3,18-divinyl-Biline-8,12-dipropionic acid
2,17-Diethenyl-1,10,19,22,23,24-hexahydro-3,7,13,18-tetramethyl-1,19-dioxo-21H-Biline-8,12-dipropanoate
2,17-Diethenyl-1,10,19,22,23,24-hexahydro-3,7,13,18-tetramethyl-1,19-dioxo-21H-Biline-8,12-dipropanoic acid
3-(2-((3-(2-Carboxyethyl)-4-methyl-5-((3-methyl-5-oxo-4-vinyl-1,5-dihydro-2H-pyrrol-2-ylidene)methyl)-1H-pyrrol-2-yl)methyl)-4-methyl-5-((4-methyl-5-oxo-3-vinyl-1,5-dihydro-2H-pyrrol-2-ylidene)methyl)-1H-pyrrol-3-yl)propanoate
3-(2-((3-(2-Carboxyethyl)-4-methyl-5-((3-methyl-5-oxo-4-vinyl-1,5-dihydro-2H-pyrrol-2-ylidene)methyl)-1H-pyrrol-2-yl)methyl)-4-methyl-5-((4-methyl-5-oxo-3-vinyl-1,5-dihydro-2H-pyrrol-2-ylidene)methyl)-1H-pyrrol-3-yl)propanoic acid
 
3-(2-((3-(2-Carboxyethyl)-4-methyl-5-[(Z)-(3-methyl-5-oxo-4-vinyl-1,5-dihydro-2H-pyrrol-2-ylidene)methyl]-1H-pyrrol-2-yl)methyl)-4-methyl-5-[(Z)-(4-methyl-5-oxo-3-vinyl-1,5-dihydro-2H-pyrrol-2-ylidene
3-[2-[[3-(2-Carboxyethyl)-5-[(3-ethenyl-4-methyl-5-oxo-pyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-2-yl]methyl]-5-[(4-ethenyl-3-methyl-5-oxo-pyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-3-yl]propanoate
3-[2-[[3-(2-Carboxyethyl)-5-[(3-ethenyl-4-methyl-5-oxo-pyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-2-yl]methyl]-5-[(4-ethenyl-3-methyl-5-oxo-pyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-3-yl]propanoic acid
3-[2-[[3-(2-Carboxyethyl)-5-[(Z)-(3-ethenyl-4-methyl-5-oxo-pyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-2-yl]methyl]-5-[(Z)-(4-ethenyl-3-methyl-5-oxo-pyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-3-yl]propanoate
3-[2-[[3-(2-Carboxyethyl)-5-[(Z)-(3-ethenyl-4-methyl-5-oxo-pyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-2-yl]methyl]-5-[(Z)-(4-ethenyl-3-methyl-5-oxo-pyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-3-yl]propanoic acid
Bilirubin
Bilirubin IX-alpha
Cholerythrin
Hematoidin
13Hormone AntagonistsPhase 1, Phase 210002
14HormonesPhase 1, Phase 211748
15Glucagon-Like Peptide 1Phase 1, Phase 2620
16glucagonPhase 1, Phase 2379
17Hormones, Hormone Substitutes, and Hormone AntagonistsPhase 1, Phase 29988
18IncretinsPhase 1, Phase 21326
19Omega 3 Fatty AcidNutraceuticalPhase 2912
20Soy BeanNutraceuticalPhase 2455
21Trace Elements3900
22Vitamins3857
23Pharmaceutical Solutions7004
24Micronutrients3901
25lysineNutraceutical77
26BifidobacteriumNutraceutical213

Interventional clinical trials:

(show all 17)
idNameStatusNCT IDPhase
1Randomized Clinical Trial of Early Delivery in Fetal Gastroschisis vs. Routine CareRecruitingNCT01884324Phase 2, Phase 3
2Metoclopramide Pilot TrialRecruitingNCT02098915Phase 3
3Trial of AMNIOECHANGE in Gastroschisis Affected FoetusesActive, not recruitingNCT00127946Phase 3
4Evaluating the Use of a Silastic Spring-Loaded Silo for Infants With GastroschisisCompletedNCT00539292Phase 2
5Compassionate Use of Omegaven in ChildrenRecruitingNCT02370251Phase 2
6Safety and Dosing Study of Glucagon-like Peptide 2 (GLP-2) in Infants and Children With Intestinal FailureTerminatedNCT01573286Phase 1, Phase 2
7PREMAPIV : Intravesical Pressure Variation at Different Bladder Instillation Volumes in Newborn ChildrenCompletedNCT01296724
8Determination of Lysine Requirement in the Parenterally Fed NeonateCompletedNCT00779753
9Silo Versus Primary Closure for GastroschisisRecruitingNCT01506531
10Sutureless vs Sutured Gastroschisis ClosureRecruitingNCT01094587
11Music Therapy: An Adjunct To Gastroschisis Infants' CareRecruitingNCT01469208
12Probiotics in Infants With GastroschisisRecruitingNCT01316510
13Clinical and Biological Outcomes of Human Milk and Formula Intake After Gastroschisis RepairRecruitingNCT02575846
14Elemental Formula in Neonates Post Small Bowel Resection: Improved Weaning From Total Parenteral Nutrition?RecruitingNCT01891279
15Gastroschisis Outcomes of Delivery (GOOD) StudyNot yet recruitingNCT02774746
16Bedside Silo Versus Operative Closure for GastroschisisTerminatedNCT00404690
17Prevention of Parenteral Nutrition-Associated Cholestasis With Cyclic Parenteral Nutrition in InfantsTerminatedNCT01062815

Search NIH Clinical Center for Gastroschisis


Cochrane evidence based reviews: gastroschisis

Genetic Tests for Gastroschisis

About this section

Anatomical Context for Gastroschisis

About this section

MalaCards organs/tissues related to Gastroschisis:

33
Skin, Liver, Breast, Lung, Bone, Testes, Brain

Animal Models for Gastroschisis or affiliated genes

About this section

MGI Mouse Phenotypes related to Gastroschisis:

38
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053698.0BMP1, ICAM1, IL6, MPO, NPPA
2MP:00053977.6ADD1, BMP1, ICAM1, IL6, MPO, NPPA
3MP:00053856.7BMP1, F5, ICAM1, IL6, MPO, NPPA
4MP:00053766.1ADD1, BMP1, F5, ICAM1, IL6, MPO

Publications for Gastroschisis

About this section

Articles related to Gastroschisis:

(show top 50)    (show all 662)
idTitleAuthorsYear
1
Singer K, Bornstein FP, Wile SA. Thrombotic thrombocytopenic purpura. Blood. 1947;2(6):542-554. (26769767)
2016
2
Conservative treatment protocol of keratocystic odontogenic tumor: report of a case with nevoid Basal cell carcinoma syndrome and literature review. (25848161)
2015
3
MC1R gene variants and sporadic malignant melanoma susceptibility in the Canary Islands population. (24170137)
2014
4
Cervix carcinoma and incidental finding of medullary thyroid carcinoma by 18F-FDG PET/CT--clinical case. (25088110)
2014
5
MicroRNAs as prognostic markers in indolent primary cutaneous B-cell lymphoma. (22936066)
2013
6
Histologic evidence of intrapulmonary anastomoses by three-dimensional reconstruction in severe bronchopulmonary dysplasia. (23987309)
2013
7
Carotid intima-media thickness in children with Kawasaki disease. (23925993)
2013
8
Mid- and long-term efficacy of the arthroscopic patellar release for treatment of patellar tendinopathy unresponsive to nonoperative management. (23830221)
2013
9
Human pathogenic fungus Trichophyton schoenleinii activates the NLRP3 inflammasome. (23686720)
2013
10
Arranging and ordering in autism spectrum disorder: characteristics, severity, and environmental correlates. (23984883)
2013
11
The expression of chemokines CCL19, CCL21 and their receptor CCR7 in oral squamous cell carcinoma and its relevance to cervical lymph node metastasis. (22976543)
2013
12
Granulosa cell tumor mutant FOXL2C134W suppresses GDF-9 and activin A-induced follistatin transcription in primary granulosa cells. (23567549)
2013
13
Further replication studies of the EVE Consortium meta-analysis identifies 2 asthma risk loci in European Americans. (23040885)
2012
14
Adenosine A(2A) receptor activation limits chronic granulomatous disease-induced hyperinflammation. (21130984)
2011
15
Metal sensitization precipitates skin blistering in epidermolysis bullosa acquisita. (20507396)
2010
16
Killing a killer: what next for smallpox? (20126444)
2010
17
Survival after laser surgery for twin-to-twin transfusion syndrome: when are they out of the woods? (19159719)
2009
18
Two Galpha(i1) rate-modifying mutations act in concert to allow receptor-independent, steady-state measurements of RGS protein activity. (19820068)
2009
19
Phosphorylation of CREB, a cyclic AMP responsive element binding protein, contributes partially to lysophosphatidic acid-induced fibroblast cell proliferation. (19285017)
2009
20
Biomarkers of left atrial volume: a longitudinal study in patients with end stage renal disease. (19635983)
2009
21
Diabetic ketoacidosis in children and adolescents with diabetes. (19754623)
2009
22
EGF and HGF levels are increased during active HBV infection and enhance survival signaling through extracellular matrix interactions in primary human hepatocytes. (18844210)
2009
23
Risk factors for endemic giardiasis: highlighting the possible association of contaminated water and food. (18377940)
2008
24
Understanding the molecular basis of celiac disease: what genetic studies reveal. (17438672)
2006
25
DNA hypermethylation of tumor-related genes in gastric carcinoma. (15831994)
2005
26
Comparing the prevalence rates of social phobia in a community according to ICD-10 and DSM-III-R. (16224610)
2005
27
A historical aspect of lysinuric protein intolerance in a northern part of Iwate, Japan. (12713148)
2003
28
Dissociation of habit-learning in Parkinson's and cerebellar disease. (11970808)
2002
29
Re-recession of the medial rectus muscles in patients with recurrent esotropia. (11753260)
2001
30
The S segment of rift valley fever phlebovirus (Bunyaviridae) carries determinants for attenuation and virulence in mice. (10627566)
2000
31
Cross-linking of CD4 induces cytoskeletal association of CD4 and p56lck. (10762057)
2000
32
Induction of endometriosis and adenomyosis by transvaginal pituitary transplantation in mice with and without natural killer cell activity. (9894569)
1998
33
Growth retardation, alopecia, pseudoanodontia, and optic atrophy (GAPO syndrome) with congenital glaucoma. (9230846)
1997
34
Specific racemization and isomerization of the aspartyl residue of alphaA-crystallin due to UV-B irradiation. (9237870)
1997
35
Interleukin-3 induces association of the protein-tyrosine phosphatase SHP2 and phosphatidylinositol 3-kinase with a 100-kDa tyrosine-phosphorylated protein in hemopoietic cells. (9361008)
1997
36
Exploring the etiology of Alzheimer disease using molecular genetics. (9052714)
1997
37
Acrosin activity in pelleted frozen sperm does not correlate with in vitro fertilization of oocytes. (9021048)
1996
38
Analysis of chaperonin-containing TCP-1 subunits in the human keratinocyte two-dimensional protein database: further characterisation of antibodies to individual subunits. (8982604)
1996
39
FISH detection of chromosome polymorphism and deletions in the spinal muscular atrophy (SMA) region of 5q13. (9067434)
1996
40
bFGF as a possible morphogen for the anteroposterior axis of the central nervous system in Xenopus. (7555736)
1995
41
Familial Noonan syndrome. (8613296)
1995
42
Immunohistochemical detection of hepatocyte growth factor/scatter factor in human cancerous and inflammatory lesions of various organs. (8276720)
1993
43
Bilateral internuclear ophthalmoplegia after smoking "crack" cocaine. (1838554)
1991
44
Direct repeats as selective response elements for the thyroid hormone, retinoic acid, and vitamin D3 receptors. (1648450)
1991
45
Lung cancer risk among pneumoconiosis patients in Japan, with special reference to silicotics. (2164508)
1990
46
Impairment of drug metabolism by the liver in experimental fascioliasis in the rat. (6139454)
1983
47
Primary suppurative parotitis. (5124870)
1971
48
Acute obstructive suppurative cholangitis. (5782750)
1969
49
Actinomycotic subdural empyema. Survival following surgical draining and antibiotic treatment. (5221230)
1966
50

Variations for Gastroschisis

About this section

Expression for genes affiliated with Gastroschisis

About this section
Search GEO for disease gene expression data for Gastroschisis.

Pathways for genes affiliated with Gastroschisis

About this section

GO Terms for genes affiliated with Gastroschisis

About this section

Biological processes related to Gastroschisis according to GeneCards Suite gene sharing:

(show all 9)
idNameGO IDScoreTop Affiliating Genes
1response to insulinGO:003286810.1IL6, NPPA
2wound healingGO:004206010.1IL6, TGFB3
3cell growthGO:001604910.0IL6, TGFB3
4regulation of MAPK cascadeGO:00434089.9BMP1, TGFB3
5positive regulation of nitric oxide biosynthetic processGO:00454299.8ICAM1, IL6
6response to amino acidGO:00432009.6ICAM1, IL6
7positive regulation of ERK1 and ERK2 cascadeGO:00703749.3ICAM1, IL6
8agingGO:00075689.2IL6, MPO, TGFB3
9cellular protein metabolic processGO:00442679.2ADD1, F5, NPPA

Sources for Gastroschisis

About this section
2CDC
14ExPASy
15FDA
16FMA
24GTR
25HGMD
26HMDB
27ICD10
28ICD10 via Orphanet
29ICD9CM
30IUPHAR
31KEGG
34MedGen
36MeSH
37MESH via Orphanet
38MGI
41NCI
42NCIt
43NDF-RT
46NINDS
47Novoseek
49OMIM
50OMIM via Orphanet
54PubMed
55QIAGEN
60SNOMED-CT via Orphanet
64Tumor Gene Family of Databases
65UMLS
66UMLS via Orphanet